DORSAVI LTD - Announcements

7.79%

4.2¢

Market Cap $38.27M

Industrials Business Equipment

dorsaVi Ltd is an Australia-based company focused on developing motion analysis device... dorsaVi Ltd is an Australia-based company focused on developing motion analysis device technologies for use in clinical applications, elite sports, and occupational health and safety. Its segments include Clinical and Workplace. The Company's products include Workplace Solutions, ViMove+, ViSafe, and Research+. Workplace Solution enables employers to assess risk of injury for employees as well as test the effectiveness of proposed changes to OHS workplace design, equipment or methods based on objective evidence. Its clinical solutions (ViMove, ViMove2 and Professional Suite) provides objective assessment, monitoring outside the clinic and immediate biofeedback. The clinical market is segmented into physical therapy (physiotherapists), hospital in the home, and elite sports. Hospital in the home refers to the remote management of patients by clinicians outside of physical therapy. Elite sports refer to the management and optimization of athletes through objective evidence.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile

See benefits

Announcements

Filter Results

All Price Sensitive Only

DVL	Three year agreement signed with UK physiotherapy network	PRICE SENSITIVE	29/09/15	92.44KB	Share
DVL	Change in Substantial Holding		25/09/15	1.27MB	Share
DVL	Change in Substantial Holding		25/09/15	378.97KB	Share
DVL	Change In Substantial Holding		25/09/15	441.8KB	Share
DVL	Change in Substantial Holding		25/09/15	474.43KB	Share
DVL	Notice of Issue of Shares		24/09/15	117.01KB	Share
DVL	Notice of Change of Exercise Price of Options		21/09/15	96.96KB	Share
DVL	Strong Support for dorsaVi Rights Issue		21/09/15	121.33KB	Share
DVL	Despatch of non-renounceable pro rata rights offer statement		04/09/15	69.33KB	Share
DVL	Change in substantial holding		03/09/15	1.1MB	Share
DVL	Change in substantial holding		03/09/15	370.17KB	Share
DVL	Rights Offer - Notice to Eligible Shareholders		26/08/15	150.43KB	Share
DVL	Notice to Option Holders		26/08/15	98.56KB	Share
DVL	Notice to Ineligible Foreign Shareholders		26/08/15	112.13KB	Share
DVL	dorsaVi Ltd 30 June 2015 Results Announcement		26/08/15	104.18KB	Share
DVL	Appendix 4E - Preliminary Final Report	PRICE SENSITIVE	26/08/15	260.25KB	Share
DVL	Appendix 3B - Rights Offer		26/08/15	277.58KB	Share
DVL	Appendix 3B - Institutional Placement		26/08/15	275.23KB	Share
DVL	Section 708AA(2)(f) Cleansing Notice		26/08/15	139.81KB	Share
DVL	Non-renounceable Rights Offer Statement	PRICE SENSITIVE	26/08/15	233.89KB	Share
DVL	Institutional Placement and Non-renounceable Rights Offer	PRICE SENSITIVE	26/08/15	129.21KB	Share
DVL	Trading Halt	PRICE SENSITIVE	24/08/15	266.76KB	Share
DVL	dorsaVi signs international achitecture firm, DesignInc		21/08/15	86.09KB	Share
DVL	dorsaVi signs Sodexo to improve workplace safety	PRICE SENSITIVE	20/08/15	105.64KB	Share
DVL	Appendix 3B		18/08/15	339.46KB	Share
DVL	dorsaVi signs New England Patriots (NFL) and two US Universi		18/08/15	121.19KB	Share
DVL	dorsaVi signs Crown Resorts, its largest contract to date.	PRICE SENSITIVE	17/08/15	91.06KB	Share
DVL	dorsaVi Conference Presentation		17/07/15	3.23MB	Share
DVL	Appendix 4C - quarterly	PRICE SENSITIVE	16/07/15	251.21KB	Share
DVL	Resignation of Chief Financial Officer		15/07/15	80.06KB	Share
DVL	dorsaVi signs NFL teams to use ViPerform		09/07/15	85.3KB	Share
DVL	ViSafe assessment on US police department		24/06/15	182.04KB	Share
DVL	dorsaVi CPT coding and US reimbursement strategy	PRICE SENSITIVE	19/06/15	92.5KB	Share
DVL	dorsaVi signs UK physiotherapy network	PRICE SENSITIVE	02/06/15	189.49KB	Share
DVL	Clinical Trial using dorsaVi shows reduction in back pain	PRICE SENSITIVE	01/06/15	428.97KB	Share
DVL	FDA approves ViMove for expanded US use	PRICE SENSITIVE	01/06/15	172.58KB	Share
DVL	ViPerform adopted by two NBA teams		28/05/15	174.29KB	Share
DVL	dorsaVi Investor Update May 2015		25/05/15	4.27MB	Share
DVL	dorsaVi secures first UK ViSafe deals	PRICE SENSITIVE	21/05/15	79.6KB	Share
DVL	dorsaVi signs first OHS deal in the US	PRICE SENSITIVE	07/05/15	82.11KB	Share
DVL	Appendix 4C - quarterly	PRICE SENSITIVE	30/04/15	194.37KB	Share
DVL	dorsaVi Investor Presentation April 2015		14/04/15	3.32MB	Share
DVL	dorsaVi OHS signs repeat customers		08/04/15	124.88KB	Share
DVL	dorsaVi announces partnerships with the NHS hospitals	PRICE SENSITIVE	27/03/15	106.52KB	Share
DVL	Appendix 3B		03/03/15	377.08KB	Share
DVL	Half Yearly Report and Accounts	PRICE SENSITIVE	27/02/15	698.16KB	Share
DVL	Appendix 4C - quarterly	PRICE SENSITIVE	30/01/15	206.59KB	Share
DVL	dorsaVi AGM Results		27/11/14	184.78KB	Share
DVL	AGM Address by Chairman and CEO		27/11/14	175.54KB	Share
DVL	dorsaVi Investor Presentation November 2014		19/11/14	3.69MB	Share
DVL	dorsaVi appoints Chief Marketing Officer In US		05/11/14	119.88KB	Share
DVL	Appendix 3B		05/11/14	223.49KB	Share
DVL	Appendix 3B		03/11/14	175.4KB	Share
DVL	Appendix 4C - quarterly	PRICE SENSITIVE	30/10/14	206KB	Share
DVL	Notice of Annual General Meeting/Proxy Form		24/10/14	860.93KB	Share
DVL	dorsaVi changing workplace behaviours to reduce injuries		16/10/14	347.84KB	Share
DVL	Annual Report to shareholders		10/10/14	1.74MB	Share
DVL	Full Year Statutory Accounts		29/09/14	578.39KB	Share
DVL	dorsaVi CEO September 2014 Investor Presentation		09/09/14	5.53MB	Share
DVL	dorsaVi September 2014 newsletter		08/09/14	620.73KB	Share
DVL	Appendix 3B		03/09/14	170.84KB	Share
DVL	dorsaVi Ltd 30 June 2014 Results Announcement		29/08/14	148.04KB	Share
DVL	Preliminary Final Report	PRICE SENSITIVE	29/08/14	197.21KB	Share
DVL	Appendix 4C - quarterly	PRICE SENSITIVE	31/07/14	199.18KB	Share
DVL	dorsaVi welcomes first US sale	PRICE SENSITIVE	23/07/14	86.35KB	Share
DVL	dorsaVi signs first South American football team		17/07/14	91.56KB	Share
DVL	ViMove receives 510k designation in US	PRICE SENSITIVE	15/07/14	93.4KB	Share
DVL	ViPerform adoption expands in UK with signing of Sunderland		08/07/14	81.55KB	Share
DVL	ViMove approved for sale in New Zealand	PRICE SENSITIVE	08/07/14	80.07KB	Share
DVL	dorsaVi acquires AWC P/L to drive OH&S market expansion	PRICE SENSITIVE	04/07/14	406.9KB	Share
DVL	Appendix 3B		04/07/14	761.38KB	Share
DVL	ViMove features on Channel 9 - A Current Affair		23/05/14	85.68KB	Share
DVL	Appendix 3B		07/05/14	223.48KB	Share
DVL	Appointment of Chief Financial Officer		07/05/14	131.94KB	Share
DVL	Appendix 4C	PRICE SENSITIVE	29/04/14	188.82KB	Share
DVL	Appendix 3B		08/04/14	165.15KB	Share
DVL	Experienced Medical Device Expert to Lead US Operations		08/04/14	129.41KB	Share
DVL	dorsaVi April 2014 Newsletter		04/04/14	514.72KB	Share
DVL	Allianz and dorsaVi partner to improve workplace safety		27/03/14	133.29KB	Share
DVL	CEO March 2014 Investor Presentation		24/03/14	3.84MB	Share
DVL	Appendix 4D and Half Year Financial Results	PRICE SENSITIVE	25/02/14	894.69KB	Share
DVL	Appendix 4C - quarterly	PRICE SENSITIVE	31/01/14	234.14KB	Share
DVL	Hawthorn Football Club adopts dorsaVi ViPerform technology		13/01/14	440.04KB	Share
DVL	First NRL deal with North Queensland Cowboys		09/01/14	524.96KB	Share
DVL	Monash University to use ViMove	PRICE SENSITIVE	23/12/13	519.82KB	Share
DVL	Initial Director's Interest Notice		12/12/13	106.83KB	Share
DVL	Initial Director's Interest Notice		12/12/13	84.85KB	Share
DVL	Initial Director's Interest Notice		12/12/13	84.42KB	Share
DVL	Initial Director's Interest Notice		12/12/13	110.74KB	Share
DVL	Initial Director's Interest Notice		12/12/13	84.87KB	Share
DVL	Becoming a substantial holder		12/12/13	952.32KB	Share
DVL	Becoming a substantial holder		12/12/13	359.99KB	Share
DVL	Becoming a substantial holder		12/12/13	445.73KB	Share
DVL	Becoming a substantial holder		12/12/13	346.15KB	Share
DVL	Olympic Park Sports Medicine Centre use of ViMove System		12/12/13	141.68KB	Share
DVL	Corporate Governance Statement		10/12/13	83.32KB	Share
DVL	Employee Share Ownership Plan		10/12/13	202.17KB	Share
DVL	dorsaVi Ltd Financial Report 2013		10/12/13	1.73MB	Share
DVL	DorsaVi Pty Ltd Financial Report 2012		10/12/13	2.8MB	Share
DVL	DorsaVi Pty Ltd Financial Report 2011		10/12/13	732.94KB	Share

DVL Three year agreement signed with UK physiotherapy network
29/09/15	PRICE SENSITIVE	92.44KB	Share
DVL Change in Substantial Holding
25/09/15		1.27MB	Share
DVL Change in Substantial Holding
25/09/15		378.97KB	Share
DVL Change In Substantial Holding
25/09/15		441.8KB	Share
DVL Change in Substantial Holding
25/09/15		474.43KB	Share
DVL Notice of Issue of Shares
24/09/15		117.01KB	Share
DVL Notice of Change of Exercise Price of Options
21/09/15		96.96KB	Share
DVL Strong Support for dorsaVi Rights Issue
21/09/15		121.33KB	Share
DVL Despatch of non-renounceable pro rata rights offer statement
04/09/15		69.33KB	Share
DVL Change in substantial holding
03/09/15		1.1MB	Share
DVL Change in substantial holding
03/09/15		370.17KB	Share
DVL Rights Offer - Notice to Eligible Shareholders
26/08/15		150.43KB	Share
DVL Notice to Option Holders
26/08/15		98.56KB	Share
DVL Notice to Ineligible Foreign Shareholders
26/08/15		112.13KB	Share
DVL dorsaVi Ltd 30 June 2015 Results Announcement
26/08/15		104.18KB	Share
DVL Appendix 4E - Preliminary Final Report
26/08/15	PRICE SENSITIVE	260.25KB	Share
DVL Appendix 3B - Rights Offer
26/08/15		277.58KB	Share
DVL Appendix 3B - Institutional Placement
26/08/15		275.23KB	Share
DVL Section 708AA(2)(f) Cleansing Notice
26/08/15		139.81KB	Share
DVL Non-renounceable Rights Offer Statement
26/08/15	PRICE SENSITIVE	233.89KB	Share
DVL Institutional Placement and Non-renounceable Rights Offer
26/08/15	PRICE SENSITIVE	129.21KB	Share
DVL Trading Halt
24/08/15	PRICE SENSITIVE	266.76KB	Share
DVL dorsaVi signs international achitecture firm, DesignInc
21/08/15		86.09KB	Share
DVL dorsaVi signs Sodexo to improve workplace safety
20/08/15	PRICE SENSITIVE	105.64KB	Share
DVL Appendix 3B
18/08/15		339.46KB	Share
DVL dorsaVi signs New England Patriots (NFL) and two US Universi
18/08/15		121.19KB	Share
DVL dorsaVi signs Crown Resorts, its largest contract to date.
17/08/15	PRICE SENSITIVE	91.06KB	Share
DVL dorsaVi Conference Presentation
17/07/15		3.23MB	Share
DVL Appendix 4C - quarterly
16/07/15	PRICE SENSITIVE	251.21KB	Share
DVL Resignation of Chief Financial Officer
15/07/15		80.06KB	Share
DVL dorsaVi signs NFL teams to use ViPerform
09/07/15		85.3KB	Share
DVL ViSafe assessment on US police department
24/06/15		182.04KB	Share
DVL dorsaVi CPT coding and US reimbursement strategy
19/06/15	PRICE SENSITIVE	92.5KB	Share
DVL dorsaVi signs UK physiotherapy network
02/06/15	PRICE SENSITIVE	189.49KB	Share
DVL Clinical Trial using dorsaVi shows reduction in back pain
01/06/15	PRICE SENSITIVE	428.97KB	Share
DVL FDA approves ViMove for expanded US use
01/06/15	PRICE SENSITIVE	172.58KB	Share
DVL ViPerform adopted by two NBA teams
28/05/15		174.29KB	Share
DVL dorsaVi Investor Update May 2015
25/05/15		4.27MB	Share
DVL dorsaVi secures first UK ViSafe deals
21/05/15	PRICE SENSITIVE	79.6KB	Share
DVL dorsaVi signs first OHS deal in the US
07/05/15	PRICE SENSITIVE	82.11KB	Share
DVL Appendix 4C - quarterly
30/04/15	PRICE SENSITIVE	194.37KB	Share
DVL dorsaVi Investor Presentation April 2015
14/04/15		3.32MB	Share
DVL dorsaVi OHS signs repeat customers
08/04/15		124.88KB	Share
DVL dorsaVi announces partnerships with the NHS hospitals
27/03/15	PRICE SENSITIVE	106.52KB	Share
DVL Appendix 3B
03/03/15		377.08KB	Share
DVL Half Yearly Report and Accounts
27/02/15	PRICE SENSITIVE	698.16KB	Share
DVL Appendix 4C - quarterly
30/01/15	PRICE SENSITIVE	206.59KB	Share
DVL dorsaVi AGM Results
27/11/14		184.78KB	Share
DVL AGM Address by Chairman and CEO
27/11/14		175.54KB	Share
DVL dorsaVi Investor Presentation November 2014
19/11/14		3.69MB	Share
DVL dorsaVi appoints Chief Marketing Officer In US
05/11/14		119.88KB	Share
DVL Appendix 3B
05/11/14		223.49KB	Share
DVL Appendix 3B
03/11/14		175.4KB	Share
DVL Appendix 4C - quarterly
30/10/14	PRICE SENSITIVE	206KB	Share
DVL Notice of Annual General Meeting/Proxy Form
24/10/14		860.93KB	Share
DVL dorsaVi changing workplace behaviours to reduce injuries
16/10/14		347.84KB	Share
DVL Annual Report to shareholders
10/10/14		1.74MB	Share
DVL Full Year Statutory Accounts
29/09/14		578.39KB	Share
DVL dorsaVi CEO September 2014 Investor Presentation
09/09/14		5.53MB	Share
DVL dorsaVi September 2014 newsletter
08/09/14		620.73KB	Share
DVL Appendix 3B
03/09/14		170.84KB	Share
DVL dorsaVi Ltd 30 June 2014 Results Announcement
29/08/14		148.04KB	Share
DVL Preliminary Final Report
29/08/14	PRICE SENSITIVE	197.21KB	Share
DVL Appendix 4C - quarterly
31/07/14	PRICE SENSITIVE	199.18KB	Share
DVL dorsaVi welcomes first US sale
23/07/14	PRICE SENSITIVE	86.35KB	Share
DVL dorsaVi signs first South American football team
17/07/14		91.56KB	Share
DVL ViMove receives 510k designation in US
15/07/14	PRICE SENSITIVE	93.4KB	Share
DVL ViPerform adoption expands in UK with signing of Sunderland
08/07/14		81.55KB	Share
DVL ViMove approved for sale in New Zealand
08/07/14	PRICE SENSITIVE	80.07KB	Share
DVL dorsaVi acquires AWC P/L to drive OH&S market expansion
04/07/14	PRICE SENSITIVE	406.9KB	Share
DVL Appendix 3B
04/07/14		761.38KB	Share
DVLViMove features on Channel 9 - A Current Affair
23/05/14		85.68KB	Share
DVLAppendix 3B
07/05/14		223.48KB	Share
DVLAppointment of Chief Financial Officer
07/05/14		131.94KB	Share
DVLAppendix 4C
29/04/14	PRICE SENSITIVE	188.82KB	Share
DVLAppendix 3B
08/04/14		165.15KB	Share
DVLExperienced Medical Device Expert to Lead US Operations
08/04/14		129.41KB	Share
DVLdorsaVi April 2014 Newsletter
04/04/14		514.72KB	Share
DVLAllianz and dorsaVi partner to improve workplace safety
27/03/14		133.29KB	Share
DVLCEO March 2014 Investor Presentation
24/03/14		3.84MB	Share
DVLAppendix 4D and Half Year Financial Results
25/02/14	PRICE SENSITIVE	894.69KB	Share
DVLAppendix 4C - quarterly
31/01/14	PRICE SENSITIVE	234.14KB	Share
DVLHawthorn Football Club adopts dorsaVi ViPerform technology
13/01/14		440.04KB	Share
DVLFirst NRL deal with North Queensland Cowboys
09/01/14		524.96KB	Share
DVLMonash University to use ViMove
23/12/13	PRICE SENSITIVE	519.82KB	Share
DVLInitial Director's Interest Notice
12/12/13		106.83KB	Share
DVLInitial Director's Interest Notice
12/12/13		84.85KB	Share
DVLInitial Director's Interest Notice
12/12/13		84.42KB	Share
DVLInitial Director's Interest Notice
12/12/13		110.74KB	Share
DVLInitial Director's Interest Notice
12/12/13		84.87KB	Share
DVLBecoming a substantial holder
12/12/13		952.32KB	Share
DVLBecoming a substantial holder
12/12/13		359.99KB	Share
DVLBecoming a substantial holder
12/12/13		445.73KB	Share
DVLBecoming a substantial holder
12/12/13		346.15KB	Share
DVLOlympic Park Sports Medicine Centre use of ViMove System
12/12/13		141.68KB	Share
DVLCorporate Governance Statement
10/12/13		83.32KB	Share
DVLEmployee Share Ownership Plan
10/12/13		202.17KB	Share
DVLdorsaVi Ltd Financial Report 2013
10/12/13		1.73MB	Share
DVLDorsaVi Pty Ltd Financial Report 2012
10/12/13		2.8MB	Share
DVLDorsaVi Pty Ltd Financial Report 2011
10/12/13		732.94KB	Share

REFRESH

First 3 4 5 6 7

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 4.2¢		Change 0.003(7.79%)		Mkt cap ! $38.27M

Open	High	Low	Value	Volume
3.9¢	4.2¢	3.9¢	$201.0K	4.991M

Buyers (Bids)

No.	Vol.	Price($)
6	1216259	4.1¢

Sellers (Offers)

Price($)	Vol.	No.
4.2¢	822419	7

View Market Depth

No.	Vol.	Price($)
6	1216259	0.041
10	1585662	0.040
6	1262402	0.039
4	3778342	0.038
1	3000000	0.037

Price($)	Vol.	No.
0.042	822419	7
0.043	779717	4
0.044	2092822	5
0.045	221846	3
0.046	133330	1

Last trade - 14.07pm 13/08/2025 (20 minute delay)


Last 4.1¢		Change 0.003 ( 6.49 %)
Open	High	Low	Volume
3.9¢	4.2¢	3.9¢	4729262
Last updated 14.07pm 13/08/2025 ?

DVL (ASX) Chart

DORSAVI LTD - Announcements

Corporate SpotlightNot Yet Available

Announcements

Buyers (Bids)

Sellers (Offers)

Top Stories

Corporate Spotlight
Not Yet Available